APELA and central nervous system cancer: As shown in Figure 5, using two independent microarray datasets for glioma (GSE33331 and GSE43289) [19,20], high APELA expression was associated with poor patient survival (p value < 0.05), both when all grades of glioma were analyzed together and when GBM patients were analyzed independently.